Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024.
Saved in:
| Title: | Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024. |
|---|---|
| Authors: | Bryce AH; Department of Medical Oncology and Therapeutics Research, City of Hope Phoenix, Phoenix, Arizona, USA., Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hussain MH; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, Illinois, USA., Sartor O; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Shore N; Carolina Urologic Research Center, Myrtle Beach, South Carolina, USA., Antonarakis ES; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, USA., Carducci MA; Hopkins Kimmel Cancer Center, Baltimore, Maryland, USA., Dorff TB; City of Hope Comprehensive Cancer Center, Duarte, California, USA., Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gleave M; Urological Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, British Columbia, Canada., Gomella LG; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Higano C; Madrona Oncology, Seattle, Washington, USA., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA., Iagaru A; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California, USA., Morgans AK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Morris DS; Urology Associates PC, Nashville, Tennessee, USA., Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Petrylak DP; Yale New Haven Health, New Haven, Connecticut, USA., Reiter RE; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA., Rettig MB; Division of Hematology-Oncology, Department of Medicine, VA Greater Los Angeles, Los Angeles, California, USA.; Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA.; Department of Urology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA., Ryan CJ; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Sellinger SB; Advanced Urology Institute, Tallahassee, Florida, USA., Spratt DE; University Hospitals Seidman Cancer Center, Cleveland, Ohio, USA., Srinivas S; Division of Medical Oncology, Stanford University Medical Center, Stanford, California, USA., Tagawa ST; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA., Taplin ME; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Yu EY; Division of Hematology and Oncology, Department of Medicine, University of Washington and Fred Hutchinson Cancer Center, Seattle, Washington, USA., Zhang T; Division of Hematology and Oncology, Department of Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA., McKay RR; Department of Urology, University of California San Diego, La Jolla, California, USA.; Department of Medicine, University of California San Diego, La Jolla, California, USA., Koo PJ; Banner MD Anderson Cancer Center, Phoenix, Arizona, USA., Crawford ED; Department of Urology, University of California San Diego, La Jolla, California, USA. |
| Source: | Cancer [Cancer] 2025 Jan 01; Vol. 131 (1), pp. e35612. Date of Electronic Publication: 2024 Dec 01. |
| Publication Type: | Journal Article; Consensus Statement |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39616467 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bryce+AH%22">Bryce AH</searchLink>; Department of Medical Oncology and Therapeutics Research, City of Hope Phoenix, Phoenix, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Agarwal+N%22">Agarwal N</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Beltran+H%22">Beltran H</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Hussain+MH%22">Hussain MH</searchLink>; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Sartor+O%22">Sartor O</searchLink>; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Shore+N%22">Shore N</searchLink>; Carolina Urologic Research Center, Myrtle Beach, South Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Antonarakis+ES%22">Antonarakis ES</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+AJ%22">Armstrong AJ</searchLink>; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Calais+J%22">Calais J</searchLink>; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Carducci+MA%22">Carducci MA</searchLink>; Hopkins Kimmel Cancer Center, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Dorff+TB%22">Dorff TB</searchLink>; City of Hope Comprehensive Cancer Center, Duarte, California, USA.<br /><searchLink fieldCode="AU" term="%22Efstathiou+JA%22">Efstathiou JA</searchLink>; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Gleave+M%22">Gleave M</searchLink>; Urological Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Gomella+LG%22">Gomella LG</searchLink>; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Higano+C%22">Higano C</searchLink>; Madrona Oncology, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Hope+TA%22">Hope TA</searchLink>; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Iagaru+A%22">Iagaru A</searchLink>; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Morgans+AK%22">Morgans AK</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Morris+DS%22">Morris DS</searchLink>; Urology Associates PC, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Morris+MJ%22">Morris MJ</searchLink>; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Petrylak+DP%22">Petrylak DP</searchLink>; Yale New Haven Health, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Reiter+RE%22">Reiter RE</searchLink>; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Rettig+MB%22">Rettig MB</searchLink>; Division of Hematology-Oncology, Department of Medicine, VA Greater Los Angeles, Los Angeles, California, USA.; Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA.; Department of Urology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Ryan+CJ%22">Ryan CJ</searchLink>; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Sellinger+SB%22">Sellinger SB</searchLink>; Advanced Urology Institute, Tallahassee, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Spratt+DE%22">Spratt DE</searchLink>; University Hospitals Seidman Cancer Center, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Srinivas+S%22">Srinivas S</searchLink>; Division of Medical Oncology, Stanford University Medical Center, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Tagawa+ST%22">Tagawa ST</searchLink>; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Taplin+ME%22">Taplin ME</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Yu+EY%22">Yu EY</searchLink>; Division of Hematology and Oncology, Department of Medicine, University of Washington and Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+T%22">Zhang T</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22McKay+RR%22">McKay RR</searchLink>; Department of Urology, University of California San Diego, La Jolla, California, USA.; Department of Medicine, University of California San Diego, La Jolla, California, USA.<br /><searchLink fieldCode="AU" term="%22Koo+PJ%22">Koo PJ</searchLink>; Banner MD Anderson Cancer Center, Phoenix, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Crawford+ED%22">Crawford ED</searchLink>; Department of Urology, University of California San Diego, La Jolla, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2025 Jan 01; Vol. 131 (1), pp. e35612. <i>Date of Electronic Publication: </i>2024 Dec 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Consensus Statement – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39616467 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cncr.35612 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e35612 Titles: – TitleFull: Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bryce AH – PersonEntity: Name: NameFull: Agarwal N – PersonEntity: Name: NameFull: Beltran H – PersonEntity: Name: NameFull: Hussain MH – PersonEntity: Name: NameFull: Sartor O – PersonEntity: Name: NameFull: Shore N – PersonEntity: Name: NameFull: Antonarakis ES – PersonEntity: Name: NameFull: Armstrong AJ – PersonEntity: Name: NameFull: Calais J – PersonEntity: Name: NameFull: Carducci MA – PersonEntity: Name: NameFull: Dorff TB – PersonEntity: Name: NameFull: Efstathiou JA – PersonEntity: Name: NameFull: Gleave M – PersonEntity: Name: NameFull: Gomella LG – PersonEntity: Name: NameFull: Higano C – PersonEntity: Name: NameFull: Hope TA – PersonEntity: Name: NameFull: Iagaru A – PersonEntity: Name: NameFull: Morgans AK – PersonEntity: Name: NameFull: Morris DS – PersonEntity: Name: NameFull: Morris MJ – PersonEntity: Name: NameFull: Petrylak DP – PersonEntity: Name: NameFull: Reiter RE – PersonEntity: Name: NameFull: Rettig MB – PersonEntity: Name: NameFull: Ryan CJ – PersonEntity: Name: NameFull: Sellinger SB – PersonEntity: Name: NameFull: Spratt DE – PersonEntity: Name: NameFull: Srinivas S – PersonEntity: Name: NameFull: Tagawa ST – PersonEntity: Name: NameFull: Taplin ME – PersonEntity: Name: NameFull: Yu EY – PersonEntity: Name: NameFull: Zhang T – PersonEntity: Name: NameFull: McKay RR – PersonEntity: Name: NameFull: Koo PJ – PersonEntity: Name: NameFull: Crawford ED IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1097-0142 Numbering: – Type: volume Value: 131 – Type: issue Value: 1 Titles: – TitleFull: Cancer Type: main |
| ResultId | 1 |